Cart
sales@molnova.com
JAK-IN-10
CAS No. 916741-98-5
JAK-IN-10( —— )
Catalog No. M33204 CAS No. 916741-98-5
JAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 120 | Get Quote |
|
| 5MG | 177 | Get Quote |
|
| 10MG | 260 | Get Quote |
|
| 25MG | 415 | Get Quote |
|
| 50MG | 585 | Get Quote |
|
| 100MG | 772 | Get Quote |
|
| 500MG | 1539 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJAK-IN-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionJAK-IN-10 is a JAK inhibitor that can be used for the research of dry eye disorders.
-
DescriptionJAK-IN-10 is a JAK inhibitor. JAK-IN-10 can be used for the research of dry eye disorders. JAK-IN-10 is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
-
In VitroJAK kinases are a family of cytoplasmic protein tyrosine kinases including JAK1, JAK2, JAK3 and TYK2. Each of the JAK kinases is selective for the receptors of certain cytokines, though multiple JAK kinases may be affected by particular cytokine or signaling pathways.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetJAK
-
RecptorJAK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number916741-98-5
-
Formula Weight427.45
-
Molecular FormulaC20H18FN5O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C=1N=C(NC2=CC=C(OCC#C)C=C2)C(F)=CN1)C3=CC(S(N)(=O)=O)=C(C)C=C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hong Ren,et al. Composition for ophthalmic administration.US20140206708A1.
molnova catalog
related products
-
Povorcitinib phospha...
Povorcitinib phosphate is a selective JAK1 inhibitor and can be used in studies about the treatment of cutaneous lupus erythematosus and Lichen planus.
-
WP1066
WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL cells.
-
BMS-986165
BMS-986165 is differentiated from previous JAK inhibitors due its unique ability to selectively bind to the pseudokinase (JH2) domain of TYK2 and inhibit its function through an allosteric mechanism.
